Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
Denise A Yardley1,2 1Sarah Cannon Research Institute, Nashville, TN, USA; 2Tennessee Oncology, Nashville, TN, USA Abstract: There is a high risk for bone loss and skeletal-related events, including bone metastases, in postmenopausal women with hormone receptor-positive breast cancer. Both the disea...
Main Author: | Yardley DA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/pharmacologic-management-of-bone-related-complications-and-bone-metast-peer-reviewed-article-BCTT |
Similar Items
-
A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression
by: Julia N. Cheng, et al.
Published: (2021-04-01) -
Complete fatty replacement of lytic bone metastases following treatment. A case report, assessing response to treatment of bone metastases on CT imaging
by: Adeola Omotade, FRCR, et al.
Published: (2024-01-01) -
Analysis of orthopedic surgery of bone metastases in breast cancer patients
by: Wegener Bernd, et al.
Published: (2012-11-01) -
Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer
by: Naoto T. Ueno, et al.
Published: (2020-02-01) -
INCIDENCE AND CLINICAL CHARACTERISTICS OF BONE METASTASES IN PATIENTS WITH BREAST CARCINOMA
by: Miodrag Projević, et al.
Published: (2003-04-01)